Pasireotide in acromegaly by aggressive tumors, description of four clinical cases. Towards a personalized medicine

Endocrinol Diabetes Nutr (Engl Ed). 2018 Feb;65(2):130-132. doi: 10.1016/j.endinu.2017.12.001. Epub 2018 Jan 20.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acromegaly / drug therapy*
  • Acromegaly / etiology
  • Adenoma / complications
  • Adenoma / pathology
  • Adult
  • Aged
  • Female
  • Hormones / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pituitary Neoplasms / complications
  • Pituitary Neoplasms / pathology
  • Precision Medicine
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use
  • Tumor Burden

Substances

  • Hormones
  • Somatostatin
  • pasireotide